{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T09:18:36Z","timestamp":1792919916085,"version":"4.5.0"},"reference-count":30,"publisher":"American Society of Hematology","issue":"12","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2002,6,15]]},"abstract":"<jats:p>We treated 45 adult patients with T-lymphoblastic lymphoma (T-LBL) (age range 15-61 years) with 2 protocols designed for adult acute lymphoblastic leukemia (ALL). An encouraging cure rate of 90% was recently reported for T-LBL in children treated with a similar approach. In our study, an 8-drug standard induction was administered over 8 weeks including prophylactic cranial (24 Gy) and mediastinal irradiation (24 Gy) followed by consolidation and reinduction therapy. At diagnosis, 91% of the 45 patients showed a mediastinal tumor and 40% had pleural\/pericardial effusions; 73% of the patients had stage III\/IV disease. Overall, 42 patients (93%) achieved a complete remission (CR), 2 patients (4%) achieved a partial remission, and 1 patient (2%) died during induction. In patients with stage I-III disease (n\u2009=\u200918) the CR rate was 100% compared with 89% in stage IV (n\u2009=\u200927). There were 15 patients who relapsed (36%) within 12 months. The majority of relapses (47%) occurred in the mediastinum (n\u2009=\u20097) despite mediastinal irradiation with 24 Gy in 6 out of 7 patients. The estimates for overall survival, continuous CR, and disease-free survival at 7 years are 51%, 65%, and 62%, respectively. Stage, age, lactate dehydrogenase, and all other parameters had no influence on achievement of CR or outcome. This study demonstrates in a large cohort of patients with adult T-LBL that a high CR rate and a favorable outcome can be achieved with an ALL-type regimen. Mediastinal recurrence was the major obstacle and further improvement by intensification of chemotherapy, increased dose of mediastinal irradiation (36 Gy), and extended indications for stem cell transplantation seem to be required.<\/jats:p>","DOI":"10.1182\/blood-2002-01-0110","type":"journal-article","created":{"date-parts":[[2002,10,11]],"date-time":"2002-10-11T14:33:52Z","timestamp":1034346832000},"page":"4379-4385","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":183,"title":["Outcome of adult patients with T-lymphoblastic lymphoma treated according to protocols for acute lymphoblastic leukemia"],"prefix":"10.1182","volume":"99","author":[{"given":"Dieter","family":"Hoelzer","sequence":"first","affiliation":[{"name":"From the Medical Clinic III, Department of Hematology, University of Frankfurt, Germany; the Department of Lymphoma, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland; the Department of Hematology, University of Freiburg, Germany; and the Department of Hematology, General Hospital St Georg, Hamburg, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Go\u0308kbuget","sequence":"additional","affiliation":[{"name":"From the Medical Clinic III, Department of Hematology, University of Frankfurt, Germany; the Department of Lymphoma, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland; the Department of Hematology, University of Freiburg, Germany; and the Department of Hematology, General Hospital St Georg, Hamburg, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Werner","family":"Digel","sequence":"additional","affiliation":[{"name":"From the Medical Clinic III, Department of Hematology, University of Frankfurt, Germany; the Department of Lymphoma, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland; the Department of Hematology, University of Freiburg, Germany; and the Department of Hematology, General Hospital St Georg, Hamburg, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Faak","sequence":"additional","affiliation":[{"name":"From the Medical Clinic III, Department of Hematology, University of Frankfurt, Germany; the Department of Lymphoma, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland; the Department of Hematology, University of Freiburg, Germany; and the Department of Hematology, General Hospital St Georg, Hamburg, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Kneba","sequence":"additional","affiliation":[{"name":"From the Medical Clinic III, Department of Hematology, University of Frankfurt, Germany; the Department of Lymphoma, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland; the Department of Hematology, University of Freiburg, Germany; and the Department of Hematology, General Hospital St Georg, Hamburg, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Regina","family":"Reutzel","sequence":"additional","affiliation":[{"name":"From the Medical Clinic III, Department of Hematology, University of Frankfurt, Germany; the Department of Lymphoma, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland; the Department of Hematology, University of Freiburg, Germany; and the Department of Hematology, General Hospital St Georg, Hamburg, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna","family":"Romejko-Jarosinska","sequence":"additional","affiliation":[{"name":"From the Medical Clinic III, Department of Hematology, University of Frankfurt, Germany; the Department of Lymphoma, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland; the Department of Hematology, University of Freiburg, Germany; and the Department of Hematology, General Hospital St Georg, Hamburg, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacek","family":"Zwolinski","sequence":"additional","affiliation":[{"name":"From the Medical Clinic III, Department of Hematology, University of Frankfurt, Germany; the Department of Lymphoma, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland; the Department of Hematology, University of Freiburg, Germany; and the Department of Hematology, General Hospital St Georg, Hamburg, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Walewski","sequence":"additional","affiliation":[{"name":"From the Medical Clinic III, Department of Hematology, University of Frankfurt, Germany; the Department of Lymphoma, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland; the Department of Hematology, University of Freiburg, Germany; and the Department of Hematology, General Hospital St Georg, Hamburg, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"key":"2020021223180934600_B1","first-page":"416","article-title":"Intensive ALL-type therapy without local radiotherapy provides a 90% event-free survival for children with T-cell lymphoblastic lymphoma: a BFM group report.","volume":"95","author":"Reiter","year":"2000","journal-title":"Blood."},{"key":"2020021223180934600_B2","doi-asserted-by":"crossref","first-page":"2648","DOI":"10.1002\/(SICI)1097-0142(19990615)85:12<2648::AID-CNCR22>3.0.CO;2-R","article-title":"B-lineage lymphoblastic lymphoma is a clinicopathologic entity distinct from other histologically similar aggressive lymphomas with blastic morphology.","volume":"85","author":"Soslow","year":"1999","journal-title":"Cancer."},{"key":"2020021223180934600_B3","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/j.1365-2141.1976.tb03563.x","article-title":"Proposals for the classification of the acute leukaemias.","volume":"33","author":"Bennett","year":"1976","journal-title":"Br J Haematol."},{"key":"2020021223180934600_B4","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3109\/10428199409052679","article-title":"Immunophenotypic features of childhood and adult acute lymphoblastic leukemia (ALL): experience of the German Multicentre Trials ALL-BFM and GMALL.","volume":"13(suppl 1)","author":"Ludwig","year":"1994","journal-title":"Leuk Lymphoma."},{"key":"2020021223180934600_B5","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/S0140-6736(88)90367-4","article-title":"Updated Kiel classification for lymphomas.","volume":"1","author":"Stansfeld","year":"1988","journal-title":"Lancet."},{"key":"2020021223180934600_B6","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1182\/blood.V84.5.1361.1361","article-title":"A revised European-American classification of lymphoid neoplasma: a proposal from the International Lymphoma Study Group.","volume":"84","author":"Harris","year":"1994","journal-title":"Blood."},{"key":"2020021223180934600_B7","first-page":"1860","article-title":"Report of the Committee on Hodgkin's Disease Staging Classification.","volume":"31","author":"Carbone","year":"1971","journal-title":"Cancer Res."},{"key":"2020021223180934600_B8","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","article-title":"Nonparametric estimation from incomplete observations.","volume":"6","author":"Kaplan","year":"1958","journal-title":"J Am Stat Assoc."},{"key":"2020021223180934600_B9","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJM199309303291402","article-title":"A predictive model for aggressive non-Hodgkin's lymphoma.","volume":"329","author":"The International Non-Hodgkin's Lymphoma Prognostic Factors Project","year":"1993","journal-title":"N Engl J Med."},{"key":"2020021223180934600_B10","first-page":"2926a","article-title":"Characteristics, outcome and risk factors in adult T-lineage acute lymphoblastic leukemia (ALL).","volume":"94","author":"Hoelzer","year":"1999","journal-title":"Blood."},{"key":"2020021223180934600_B11","first-page":"332","article-title":"Classification, staging and end results of treatment of childhood non-Hodgkin's lymphomas: dissimilarities from lymphomas in adults.","volume":"7","author":"Murphy","year":"1980","journal-title":"Semin Oncol."},{"key":"2020021223180934600_B12","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1182\/blood.V57.1.186.186","article-title":"The chemotherapy of lymphoblastic lymphoma.","volume":"57","author":"Voakes","year":"1981","journal-title":"Blood."},{"key":"2020021223180934600_B13","doi-asserted-by":"crossref","first-page":"291","DOI":"10.3109\/10428199409049726","article-title":"Long-term follow-up of a CHOP-based regimen with maintenance therapy and central nervous system prophylaxis in lymphoblastic non-Hodgkin's lymphoma.","volume":"15","author":"Colgan","year":"1994","journal-title":"Leuk Lymphoma."},{"key":"2020021223180934600_B14","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1023\/A:1008202808144","article-title":"Role of induction chemotherapy and bone marrow transplantation in adult lymphoblastic lymphoma: a report on 62 patients from a single center.","volume":"9","author":"Bouabdallah","year":"1998","journal-title":"Ann Oncol."},{"key":"2020021223180934600_B15","doi-asserted-by":"crossref","first-page":"101","DOI":"10.3109\/10428199909145953","article-title":"Non-Hodgkin's lymphoma protocols in the treatment of patients with Burkitt's lymphoma and lymphoblastic lymphoma: a report on 58 patients.","volume":"36","author":"Kaiser","year":"1999","journal-title":"Leuk Lymphoma."},{"key":"2020021223180934600_B16","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1200\/JCO.1986.4.11.1628","article-title":"Treatment of lymphoblastic lymphoma in adults.","volume":"4","author":"Coleman","year":"1986","journal-title":"J Clin Oncol."},{"key":"2020021223180934600_B17","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1200\/JCO.1986.4.1.57","article-title":"Lymphoblastic lymphoma in adults.","volume":"4","author":"Slater","year":"1986","journal-title":"J Clin Oncol."},{"key":"2020021223180934600_B18","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1093\/oxfordjournals.annonc.a057692","article-title":"Lymphoblastic lymphoma in adult patients: clinicopathological features and response to intensive multiagent chemotherapy analogous to that used in acute lymphoblastic leukemia.","volume":"1","author":"Bernasconi","year":"1990","journal-title":"Ann Oncol."},{"key":"2020021223180934600_B19","first-page":"754a","article-title":"Outcome of a hybrid chemotherapy regimen with mediastinal irradiation in leukemic T-lymphoblastic lymphoma.","volume":"86","author":"Daenen","year":"1995","journal-title":"Blood."},{"key":"2020021223180934600_B20","doi-asserted-by":"crossref","first-page":"577","DOI":"10.3109\/10428199609054867","article-title":"Adult lymphoblastic lymphoma: clinical features and prognostic factors in 53 patients.","volume":"23","author":"Zinzani","year":"1996","journal-title":"Leuk Lymphoma."},{"key":"2020021223180934600_B21","first-page":"38a","article-title":"Outcome with the hyper-CVAD regimen in lymphoblastic lymphoma.","volume":"18","author":"Thomas","year":"1999","journal-title":"Proc ASCO."},{"key":"2020021223180934600_B22","doi-asserted-by":"crossref","first-page":"3909","DOI":"10.1182\/blood.V89.11.3909","article-title":"A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma.","volume":"89","author":"The Non-Hodgkin's Lymphoma Classification Project","year":"1997","journal-title":"Blood."},{"key":"2020021223180934600_B23","first-page":"1391a","article-title":"Lymphoblastic lymphoma: results of a prospective treatment trial (BMFT study).","volume":"93","author":"Engelhard","year":"1996","journal-title":"Br J Haematol."},{"key":"2020021223180934600_B24","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1200\/JCO.1995.13.6.1368","article-title":"Comparison of treatment regimens for pediatric lymphoblastic non-Hodgkin's lymphoma: a Children's Cancer Group study.","volume":"13","author":"Tubergen","year":"1995","journal-title":"J Clin Oncol."},{"key":"2020021223180934600_B25","first-page":"221","article-title":"Intensified chemotherapy and mediastinal irradiation in adult T-cell acute lymphoblastic leukemia","volume-title":"Acute Lymphoblastic Leukemia.","author":"Hoelzer","year":"1990"},{"key":"2020021223180934600_B26","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/sj.leu.2401310","article-title":"Intensive high-dose asparaginase consolidation improves survival for pediatric patients with T cell acute lymphoblastic leukemia and advanced stage lymphoblastic lymphoma: a Pediatric Oncology Group study.","volume":"13","author":"Amylon","year":"1999","journal-title":"Leukemia."},{"key":"2020021223180934600_B27","first-page":"3310","article-title":"Improved outcome in childhood acute lymphoblastic leukemia despite reduced use of anthracyclines and cranial radiotherapy: results of trial ALL-BFM 90. German-Austrian-Swiss ALL-BFM Study Group.","volume":"95","author":"Schrappe","year":"2000","journal-title":"Blood."},{"key":"2020021223180934600_B28","first-page":"1088","article-title":"Fractionated cyclophosphamide added to the IVAP regimen (idarubicin-vincristine-L-asparaginase-prednisone) could lower the risk of primary refractory disease in T-lineage but not B-lineage acute lymphoblastic leukemia: first results from a phase II clinical study.","volume":"84","author":"Bassan","year":"1999","journal-title":"Haematologica."},{"key":"2020021223180934600_B29","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1200\/JCO.1994.12.7.1358","article-title":"High-dose therapy and autologous bone marrow transplantation for adult patients with lymphoblastic lymphoma: results of the European Group for Bone Marrow Transplantation.","volume":"12","author":"Sweetenham","year":"1994","journal-title":"J Clin Oncol."},{"key":"2020021223180934600_B30","first-page":"2666a","article-title":"2-amino-9-B-D-arabinosyl-6-methoxy-9H-guanine (GW506U; compound 506U) is highly active in patients with T-cell malignancies: results of a phase I trial in pediatric and adult patients with refractory hematological malignancies.","volume":"88","author":"Kurtzberg","year":"1996","journal-title":"Blood."}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/99\/12\/4379\/1685356\/h81202004379.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/99\/12\/4379\/1685356\/h81202004379.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,12]],"date-time":"2020-02-12T23:18:21Z","timestamp":1581549501000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/99\/12\/4379\/105897\/Outcome-of-adult-patients-with-Tlymphoblastic"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,6,15]]},"references-count":30,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2002,6,15]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2002-01-0110","relation":{},"ISSN":["1528-0020","0006-4971"],"issn-type":[{"value":"1528-0020","type":"electronic"},{"value":"0006-4971","type":"print"}],"subject":[],"published":{"date-parts":[[2002,6,15]]}}}